ETAA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.014090E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.827210E-01
Normal-vs-Stage2
7.040200E-03
Normal-vs-Stage3
1.143360E-03
Normal-vs-Stage4
2.055600E-01
Stage1-vs-Stage2
2.986600E-01
Stage1-vs-Stage3
8.204200E-02
Stage1-vs-Stage4
7.240800E-01
Stage2-vs-Stage3
8.655800E-02
Stage2-vs-Stage4
8.398800E-01
Stage3-vs-Stage4
3.377400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.080100E-03
Normal-vs-AfricanAmerican
1.756030E-01
Normal-vs-Asian
2.647900E-02
Caucasian-vs-AfricanAmerican
5.708200E-01
Caucasian-vs-Asian
4.172800E-01
AfricanAmerican-vs-Asian
4.579000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.060100E-03
Normal-vs-Female
2.915800E-02
Male-vs-Female
3.308000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.720100E-02
Normal-vs-Age(41-60Yrs)
1.807900E-02
Normal-vs-Age(61-80Yrs)
9.397600E-03
Normal-vs-Age(81-100Yrs)
2.637700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.748200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.900600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.611800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.961700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.208000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.603200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.961500E-03
Normal-vs-Daily Drinker
4.742200E-03
Normal-vs-Weekly Drinker
1.389540E-02
Normal-vs-Occasional Drinker
6.862000E-02
Normal-vs-Social Drinker
3.681800E-02
Non Drinker-vs-Daily Drinker
6.793800E-01
Non Drinker-vs-Weekly Drinker
5.387400E-01
Non Drinker-vs-Occasional Drinker
3.488600E-01
Non Drinker-vs-Social Drinker
4.890200E-02
Daily Drinker-vs-Weekly Drinker
7.986000E-01
Daily Drinker-vs-Occasional Drinker
2.401800E-01
Daily Drinker-vs-Social Drinker
2.872200E-02
Weekly Drinker-vs-Occasional Drinker
2.408600E-01
Weekly Drinker-vs-Social Drinker
3.964200E-02
Occasional Drinker-vs-Social Drinker
4.494000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.055800E-02
Normal-vs-Grade 2
8.918800E-03
Normal-vs-Grade 3
6.161400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.604200E-01
Grade 1-vs-Grade 3
3.890500E-02
Grade 1-vs-Grade 4
5.055800E-02
Grade 2-vs-Grade 3
1.163970E-01
Grade 2-vs-Grade 4
8.918800E-03
Grade 3-vs-Grade 4
6.161400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.484200E-03
Normal-vs-NonDiabetic
5.555700E-03
Diabetic-vs-NonDiabetic
2.561200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.069610E-02
Normal-vs-NoPancreatitis
5.458900E-03
Pancreatitis-vs-NoPancreatitis
8.822400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.825700E-02
Normal-vs-N1
6.784300E-03
N0-vs-N1
8.965000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.177900E-02
Normal-vs-TP53-NonMutant
5.463800E-02
TP53-Mutant-vs-TP53-NonMutant
6.120800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
